EUROPE STEM CELL MARKET FORECAST 2021-2028

EUROPE STEM CELL MARKET FORECAST 2021-2028

  • November 2020 •
  • Report ID: 4807894 •
  • Format: PDF
KEY FINDINGS
The Europe stem cell market is predicted to register a CAGR of 8.03%, over the forecast period of 2021 to 2028. The region’s market growth is fueled by factors such as, significant investments across areas like medical research and healthcare facilities, the growing medical tourism, and the increased prevalence of chronic diseases.

MARKET INSIGHTS
The Europe stem cell market growth is determined by assessing the United Kingdom, Poland, France, Germany, Belgium, Russia, Italy, and the rest of Europe.Russia is fairly new to the Biomedical Cell Products (BCP), and the year 2018 marked a major breakthrough for the Russian market as well as the global pharmaceutical arena.

The country’s government passed a law incorporating amendments to the biomedical cell product guidelines, which officially initiated Russia into the stem cell technologies industry.Moreover, the country’s healthcare and pharmaceutical sectors hold significant potential for stem cell studies, in addition to clinical trials in general.

Russia’s key strengths include massive clinical trial participation, prompt patient enrolment, and favorable currency exchange rates.
According to the data published in 2019, Belgium harbored more than 800,000 individuals aged between 50 and 54, and nearly 90,000 people within the age bracket of 90 and 94. Likewise, over 24% of Belgium’s population was over 60 years in 2017, and this figure is expected to increase to 32.4%, by 2050. Therefore, Belgium’s stem cell market is anticipated to observe a growing trend over the upcoming years, due to the surge in the country’s geriatric population. Hence, these factors are influential in driving the market growth during the forecast period.

COMPETITIVE INSIGHTS
Key enterprises operating in the market include, Qiagen NV, Miltenyi Biotec, Smith & Nephew PLC, Merck KGaA, etc.

Companies mentioned
1. ALLCELLS LLC
2. BECTON, DICKINSON AND COMPANY (BD)
3. CORNING INC
4. CYTORI THERAPEUTICS
5. GE HEALTHCARE
6. INTERNATIONAL STEM CELL CORP
7. MERCK KGAA (SIGMA ALDRICH)
8. MILTENYI BIOTEC
9. PLURISTEM THERAPEUTICS INC
10. QIAGEN NV
11. SMITH & NEPHEW PLC
12. STEMCELL TECHNOLOGIES
13. STRYKER CORPORATION
14. TAKARA HOLDINGS INC
15. THERMO FISHER SCIENTIFIC INC